Under construction – not a live service

Skip to content

Frontlight Research

Researcher profile · from public sources

Zhangding Wang

First Affiliated Hospital of Anhui Medical University, ChinaORCID 0000-0002-3959-45424 publications · 0 trials

This is me: claim the profile

Targets

EGFR 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

Publication
Targeting the N-acetyltransferase 10/DKK2 axis enhances CD8+ T cell antitumor activity in colorectal cancer models.
The Journal of clinical investigation, Jan 2026
Publication
RBM8A confers oxaliplatin resistance in gastric cancer by maintaining EGFR mRNA stability.
Oncogene, Dec 2025
Publication
Pharmacological induction of acetyl-CoA carboxylase 1 autophagic degradation attenuates lipid accumulation and cholangiocarcinoma progression.
Journal of experimental & clinical cancer research : CR, Nov 2025
Publication
PSMD14-mediated PFKFB2 deubiquitination activates H3K27 lactylation to drive cancer stemness in gastric adenocarcinoma.
Cell death and differentiation, Nov 2025

Affiliations

First Affiliated Hospital of Anhui Medical University

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.

Sources: OpenAlex · Updated 4 Nov 2025This is not me Correct something Object to this profile

Is this you? Request a correction or removal: support@frontlightresearch.com

Report an error

Under construction, not live – Zhangding Wang: research profile – Frontlight Research